|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0001675,
umls-concept:C0022885,
umls-concept:C0039593,
umls-concept:C0065601,
umls-concept:C0112154,
umls-concept:C0205178,
umls-concept:C0205307,
umls-concept:C0442027,
umls-concept:C0547047,
umls-concept:C0871261,
umls-concept:C1704410,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-1-21
|
|
pubmed:abstractText |
An examination was conducted to verify D-psicose suppressed the elevation of blood glucose and insulin concentration in a dose-dependent manner under the concurrent administration of maltodextrin and D-psicose to healthy humans. Twenty subjects aged 20-39 y, 11 males and 9 females were recruited. A load test of oral maltodextrin was conducted as a randomized single blind study. The subjects took one of five test beverages (7.5 g D-psicose alone, 75 g maltodextrin alone, 75 g maltodextrin +2.5, 5 or 7.5 g D-psicose). Blood was collected before an intake and at 30, 60, 90 and 120 min after an intake. Intervals of administration were at least 1 wk. The load test with 75 g maltodextrin showed significant suppressions of the elevation of blood glucose and insulin concentration under the doses of 5 g or more D-psicose with dose dependency. An independent administration of 7.5 g D-psicose had no influence on blood glucose or insulin concentration. D-Psicose is considered efficacious in the suppression of the elevation of blood glucose concentration after eating in humans.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0301-4800
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
511-4
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19155592-Administration, Oral,
pubmed-meshheading:19155592-Adult,
pubmed-meshheading:19155592-Beverages,
pubmed-meshheading:19155592-Blood Glucose,
pubmed-meshheading:19155592-Dietary Carbohydrates,
pubmed-meshheading:19155592-Dose-Response Relationship, Drug,
pubmed-meshheading:19155592-Female,
pubmed-meshheading:19155592-Fructose,
pubmed-meshheading:19155592-Glucose,
pubmed-meshheading:19155592-Glucose Tolerance Test,
pubmed-meshheading:19155592-Humans,
pubmed-meshheading:19155592-Insulin,
pubmed-meshheading:19155592-Japan,
pubmed-meshheading:19155592-Male,
pubmed-meshheading:19155592-Polysaccharides,
pubmed-meshheading:19155592-Single-Blind Method,
pubmed-meshheading:19155592-Sweetening Agents,
pubmed-meshheading:19155592-Young Adult
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Acute D-psicose administration decreases the glycemic responses to an oral maltodextrin tolerance test in normal adults.
|
|
pubmed:affiliation |
Research Institute, Matsutani Chemical Industry Co., Ltd., Kita-Itami, Itami, Japan. tetsuo-iida@matsutani.co.jp
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
